These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 8318480)
1. Effect of topical ketanserin administration on intraocular pressure. Costagliola C; Iuliano G; Rinaldi M; Russo V; Scibelli G; Mastropasqua L Br J Ophthalmol; 1993 Jun; 77(6):344-8. PubMed ID: 8318480 [TBL] [Abstract][Full Text] [Related]
2. Effect of oral ketanserin administration on intraocular pressure in glaucomatous patients. Costagliola C; Scibelli G; Fasano ML; Ferrara LA; Mastropasqua L Exp Eye Res; 1991 May; 52(5):507-10. PubMed ID: 2065721 [TBL] [Abstract][Full Text] [Related]
3. Effect of ketanserin administration on intraocular pressure. Tekat D; Güler C; Arici M; Topalkara A; Erdoğan H Ophthalmologica; 2001; 215(6):419-23. PubMed ID: 11741108 [TBL] [Abstract][Full Text] [Related]
4. Ocular hypotensive effect of topical ketanserin in timolol users. Mastropasqua L; Ciancaglini M; Carpineto P; Costagliola C Graefes Arch Clin Exp Ophthalmol; 1997 Mar; 235(3):130-5. PubMed ID: 9085107 [TBL] [Abstract][Full Text] [Related]
5. Effect of oral losartan potassium administration on intraocular pressure in normotensive and glaucomatous human subjects. Costagliola C; Verolino M; De Rosa ML; Iaccarino G; Ciancaglini M; Mastropasqua L Exp Eye Res; 2000 Aug; 71(2):167-71. PubMed ID: 10930321 [TBL] [Abstract][Full Text] [Related]
6. Effects of ketanserin on intraocular pressure. Costagliola C; Fasano ML; Iuliano G; Ferrara LA Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():97-9. PubMed ID: 2285657 [TBL] [Abstract][Full Text] [Related]
7. Effect of oral captopril (SQ 14225) on intraocular pressure in man. Costagliola C; Di Benedetto R; De Caprio L; Verde R; Mastropasqua L Eur J Ophthalmol; 1995; 5(1):19-25. PubMed ID: 7795397 [TBL] [Abstract][Full Text] [Related]
8. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial. Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767 [TBL] [Abstract][Full Text] [Related]
9. Effect of oral bromocriptine administration on intraocular pressure in normotensive and glaucomatous human subjects. Costagliola C; Carella C; Amato G; Winkler NR; Scibelli G; Iaccarino G; Mastropasqua L J Glaucoma; 1995 Dec; 4(6):386-90. PubMed ID: 19920704 [TBL] [Abstract][Full Text] [Related]
10. The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study. Dinslage S; Hueber A; Diestelhorst M; Krieglstein G Graefes Arch Clin Exp Ophthalmol; 2004 Aug; 242(8):654-60. PubMed ID: 15241610 [TBL] [Abstract][Full Text] [Related]
11. Effect of topical pergolide on aqueous dynamics in normal and glaucomatous monkeys. Siegel MJ; Lee PY; Podos SM; Mittag TW Exp Eye Res; 1987 Feb; 44(2):227-33. PubMed ID: 3582509 [TBL] [Abstract][Full Text] [Related]
12. Effects of topical H-7 on outflow facility, intraocular pressure, and corneal thickness in monkeys. Tian B; Wang RF; Podos SM; Kaufman PL Arch Ophthalmol; 2004 Aug; 122(8):1171-7. PubMed ID: 15302658 [TBL] [Abstract][Full Text] [Related]
13. Topical verapamil and episcleral venous pressure. Abreu MM; Kim YY; Shin DH; Netland PA Ophthalmology; 1998 Dec; 105(12):2251-5. PubMed ID: 9855155 [TBL] [Abstract][Full Text] [Related]
14. Effect of topical latanoprost 0.005% on intraocular pressure and pupil diameter in normal and glaucomatous cats. McDonald JE; Kiland JA; Kaufman PL; Bentley E; Ellinwood NM; McLellan GJ Vet Ophthalmol; 2016 Jul; 19 Suppl 1(Suppl 1):13-23. PubMed ID: 26183373 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma. Christiansen GA; Nau CB; McLaren JW; Johnson DH Ophthalmology; 2004 Sep; 111(9):1658-62. PubMed ID: 15350319 [TBL] [Abstract][Full Text] [Related]
16. Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost. Costagliola C; Campa C; Perri P; Parmeggiani F; Romano MR; Incorvaia C Curr Eye Res; 2008 May; 33(5):477-82. PubMed ID: 18568885 [TBL] [Abstract][Full Text] [Related]
17. Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans. Kanno M; Araie M; Koibuchi H; Masuda K Br J Ophthalmol; 2000 Mar; 84(3):293-9. PubMed ID: 10684841 [TBL] [Abstract][Full Text] [Related]
18. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal dogs. Miller PE; Nelson MJ; Rhaesa SL Am J Vet Res; 1996 Jan; 57(1):79-82. PubMed ID: 8720243 [TBL] [Abstract][Full Text] [Related]
19. Effects of systemic administration of 0.5% tropicamide on intraocular pressure, pupillary diameter, blood pressure, and heart rate in normal cats. Schmidt KS; Hacker DV; Kass PH; Barkhoodarian AL Vet Ophthalmol; 2006; 9(2):137-9. PubMed ID: 16497239 [TBL] [Abstract][Full Text] [Related]
20. Effect of flunarizine, a calcium channel blocker, on intraocular pressure and aqueous humor dynamics in monkeys. Wang RF; Gagliuso DJ; Podos SM J Glaucoma; 2008; 17(1):73-8. PubMed ID: 18303390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]